Carlsmed

Forecast & Rating5 analysts currently cover Carlsmed, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $18.60, about 72.2% upside from the current price of $10.80. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study Carlsmed closely still see room for the stock to rise. Data as of Jul 15, 2026; for reference only and not investment advice.